Related Experiment Videos
Coexistent bronchogenic carcinoma and active pulmonary tuberculosis
The Journal of Thoracic and Cardiovascular Surgery
|October 1, 1978
Summary
This study on coexisting lung cancer and tuberculosis found that most patients were male smokers. Treatment achieved high sputum conversion rates, but survival remained poor, suggesting diseases progressed independently.
Area of Science:
- Pulmonology
- Oncology
- Infectious Diseases
Background:
- Coexistence of bronchogenic carcinoma and active pulmonary tuberculosis presents diagnostic and therapeutic challenges.
- Understanding the clinical course and outcomes of these dual infections is crucial for patient management.
Purpose of the Study:
- To analyze the clinical characteristics, treatment outcomes, and survival rates of patients with coexistent lung cancer and tuberculosis.
- To evaluate the interaction between these two diseases in terms of their individual progression and impact on patient prognosis.
Main Methods:
- Retrospective review of 64 cases diagnosed between 1969 and 1976.
- Analysis of patient demographics, smoking history, type of bacilli, drug resistance, treatment modalities (antituberculous drugs, pulmonary resection, chemotherapy), and survival data.
Main Results:
- Majority of patients were male chronic cigarette smokers in their fifth and sixth decades.
- High sputum conversion rate (93.8%) with antituberculous drugs; however, drug resistance was noted in atypical bacilli and some human bacilli.
- Pulmonary resection was performed in 70.3% of patients. Survival rates were low across all treatment groups, with median survival ranging from 8.3 to 14.3 months.
Conclusions:
- Coexistent lung cancer and tuberculosis appear to follow independent clinical courses with minimal impact on each other.
- Despite successful sputum conversion, overall survival remains significantly limited, highlighting the poor prognosis associated with this dual pathology.